CJ Bioscience, Inc. (KOSDAQ:311690)

CJ Bioscience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	112,232	131,831	147,076	170,481	286,048	199,288
Market Cap Growth	-10.43%	-10.37%	-13.73%	-40.40%	43.54%	39.15%
Enterprise Value	64,641	98,118	116,989	139,502	291,080	185,214
Last Close Price	8590.00	10090.00	16140.00	24887.51	41793.85	43939.33
PS Ratio	33.25	38.03	26.38	41.84	65.56	37.52
PB Ratio	1.90	1.70	2.06	3.43	3.26	5.78
P/TBV Ratio	2.37	2.02	2.49	3.51	3.26	5.80
EV/Sales Ratio	19.15	28.30	20.98	34.24	66.72	34.87
Debt / Equity Ratio	0.14	0.12	0.12	0.58	0.27	1.04
Net Debt / Equity Ratio	-0.80	-0.85	-0.78	-0.41	-0.64	-0.10
Net Debt / EBITDA Ratio	1.88	2.20	2.07	0.69	6.58	0.47
Net Debt / FCF Ratio	1.86	2.34	1.86	0.81	5.98	0.18
Asset Turnover	0.05	0.04	0.06	0.04	0.05	0.10
Inventory Turnover	14.15	22.21	32.50	24.90	10.67	13.27
Quick Ratio	3.84	4.10	4.38	1.43	3.39	13.19
Current Ratio	3.89	4.14	4.43	1.46	3.42	13.68
Return on Equity (ROE)	-52.81%	-44.00%	-37.82%	-50.78%	-31.51%	-26.82%
Return on Assets (ROA)	-25.61%	-22.44%	-21.95%	-20.00%	-6.66%	-9.94%
Return on Capital Employed (ROCE)	-47.80%	-42.20%	-42.00%	-58.90%	-10.90%	-12.10%
Earnings Yield	-25.23%	-24.91%	-15.58%	-20.48%	-6.74%	-4.40%
FCF Yield	-22.82%	-21.34%	-20.28%	-14.73%	-3.28%	-10.03%
Buyback Yield / Dilution	-34.22%	-30.93%	-20.52%	-38.23%	-10.14%	-16.93%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.